AbbVie Loses India Patent Bid for Cancer Drug Venetoclax, Generics Set to Enter Market
New Delhi: In a major development for cancer drug accessibility in India, the Indian Patent Office (IPO) has rejected a patent application filed by multinational pharmaceutical company AbbVie for its…